Stephen will be responsible for Genetix’ R&D function, managing its expertise in software analysis, imaging, biology and robotics, and ensuring its R&D activities are aligned to market opportunities.
Stephen joins Genetix from GE Healthcare Life Sciences (GE) where he is currently a Technology Manager in Cellular Science. Stephen’s responsibilities include team management, strategic development and product portfolio management. Before GE acquired Amersham BioSciences, Stephen held a number of senior roles at Amersham - most recently as Department Director of Molecular Cell Biology, responsible for 35 staff and accountable for the strategic development of the department. Stephen holds a PhD in Biochemistry from the University of Bath.
Charles de Rohan, Chief Executive of Genetix, said:
“With more than 17 years of industry experience, Stephen brings extensive knowledge and expertise to the business and is a strong addition to the Management Team. Stephen’s wide-ranging management and leadership skills will be of great value to Genetix as the Company continues to build its position in the fast-growing markets of biopharmaceutical drug discovery and cancer diagnostics.”
Enquiries:
Genetix Group plc Charles de Rohan, Chief Executive Tel: +44 (0) 1425 624600 Andrew Kellett, Finance Director
Financial Dynamics Jonathan Birt/Lara Mott Tel: +44 (0) 20 7831 3113
